Dianthus Therapeutics

DNTH

Börsenwert 4,61 Mrd. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 TRV GP IV Boston, Massachusetts	9,5 Mio. $	–	–	–
2	2 Deep Track Capital Greenwich, Connecticut	7,56 Mio. $	–	–	–
3	3 RA Capital Management Boston, Massachusetts	5,06 Mio. $	+6,14 Mio. $	+224.255	Neu
4	4 Atlas Venture Life Science Advisors Cambridge, Massachusetts	4,9 Mio. $	–	–	–
5	5 Janus Henderson Group London,	4,75 Mio. $	+522.089 $	+19.070	+10 %
6	6 Alphabet Inc Mountain View, California	4,71 Mio. $	–	–	–
7	7 OrbiMed New York	3,17 Mio. $	–	–	–
8	8 TCG Crossover Management Palo Alto, California	3 Mio. $	–	–	–
9	9 Millennium Management New York	2,95 Mio. $	+376.358 $	+13.747	+12 %
10	10 Vanguard Group Malvern, Pennsylvania	2,77 Mio. $	+95.246 $	+3.479	+3 %
11	11 Woodline Partners San Francisco, California	1,84 Mio. $	+636.116 $	+23.235	+40 %
12	12 Wellington Management Group Boston, Massachusetts	1,81 Mio. $	-15.633 $	-571	-0,7 %
13	13 Great Point Partners Greenwich, Connecticut	1,44 Mio. $	-258.225 $	-9.432	-13 %
14	14 Adage Capital Partners Boston, Massachusetts	1,15 Mio. $	+192.847 $	+7.044	+16 %
15	15 BlackRock New York	1,04 Mio. $	-98.340 $	-3.592	-7 %
16	16 Gilder Gagnon Howe & Co New York	994.000 $	-69.758 $	-2.548	-5 %
17	17 Laurion Capital Management New York	821.000 $	–	–	–
18	18 Bleichroeder LP New York	683.000 $	–	–	–
19	19 Palo Alto Investors Palo Alto, California	610.000 $	–	–	–
20	20 Renaissance Technologies New York	571.000 $	-558.665 $	-20.406	-45 %
21	21 Integral Health Asset Management New York	532.000 $	+83.392 $	+3.046	+15 %
22	22 RBF Capital San Francisco, California	524.000 $	–	–	–
23	23 Geode Capital Management Boston, Massachusetts	494.000 $	+11.225 $	+410	+2 %
24	24 Harvard Management Company Boston, Massachusetts	469.000 $	–	–	–
25	25 Casdin Capital New York	451.000 $	-3,58 Mio. $	-130.938	-87 %

Dianthus Therapeutics DNTH Börsenwert 4,61 Mrd. $

Dianthus Therapeutics

DNTH

Börsenwert 4,61 Mrd. $